The 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019)
A preview of the upcoming 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which is due to be held on 15–18 September 2019 at the Convention Centre of The Dan Panorama Hotel in Tel Aviv, Israel.
allegro60/stock.adobe.com
A preview of the upcoming 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which is due to be held on 15–18 September 2019 at the Convention Centre of The Dan Panorama Hotel in Tel Aviv, Israel.
The organizing committee invites you to attend the 30th International Symposium on Pharmaceutical and Biomedical Analysis (PBA 2019), which will be held 15–18 September 2019 at the Convention Centre of The Dan Panorama hotel in Tel Aviv, Israel.
It follows a series of successful PBA symposia organized all over the world since 1987, when the first International Symposium on Pharmaceutical and Biomedical Analysis (PBA) was launched in Barcelona, Spain. Now, for the first time in its history, the symposium arrives in the Middle East.
The symposium will cover all aspects of pharmaceutical and biomedical analysis, including new analytical technologies and methodologies for (bio)pharmaceuticals, biomarkers, and “omics”. A special session will be focused on the emerging field of medical cannabis. It is in the spirit of this symposium series to attract researchers from all over the world, from a broad range of areas involved in drug analysis, related materials, and endogenous compounds.
Plenary and keynote lectures will be given by internationally recognized invited speakers. A number of materials will be presented as oral communications and poster presentations. Participation of young researchers, both from industry and academia, will be strongly supported by a dedicated young scientist session, best oral presentation, and poster awards, as well as a reduced registration fee and affordable lodging.
Photo credit: Bioforum
PBA 2019 will also offer stimulating and highly informative workshops by recognized experts in their field; these will be run in parallel on Sunday 15 September from 9:00 to 13:00. These workshops include:
- “Solid-phase microextraction (SPME) in medical and translational research” given by Janusz Pawliszyn and Barbara Bojko from Waterloo University, Canada
- “Advanced CE–MS and NMR approaches for metabolomics” given by Rawi Ramautar and Oleg Mayboroda from Leiden University, the Netherlands
- “API solid state characterization in preformulation studies” given by Judith Aronhime, consultant on pharmaceutical polymorphism and solid state analysis, Israel
Participants are also invited to submit manuscripts based on presentations at the PBA 2019 meeting for possible publication in the Journal of Pharmaceutical and Biomedical Analysis (JPBA), with the intention of publishing a special issue dedicated to the meeting. Such special issue publications essentially rule out possible delays for contributors.
One of the major aims of the symposium is to provide a forum for highâlevel scientific exchange between analytically oriented scientists from the whole world in a friendly atmosphere.
Tel Aviv, with its special cosmopolitan atmosphere, can offer excellent opportunities for scientific, cultural, and social experiences in a unique Mediterranean seaside setting. The symposium venue is located within walking distance from Old Jaffa. This ancient city with more than 3000 years’ history is in the oldest part of Tel Aviv, and is famous for its association with the biblical stories of Jonah, Solomon, and Saint Peter, as well as the mythological story of Andromeda and Perseus.
An attractive programme of social events will also be arranged during the symposium, including a full-day guided tour to Jerusalem on 19 September.
As a country geographically bridging Europe, Asia, and Africa and located on the crossroads of culture and religion, Israel enjoys the established status as one of the most popular tourist destinations.
The organizers look forward to seeing you in September 2019 and wish you a fruitful and enjoyable stay in Israel.
More details on the topics, invited speakers, registration, abstract submission, conference fees, and important dates can be found on the conference website: www.pba2019.org.
Vladimir Ioffe
PBA-2019 Chairmanvladimir.ioffe@teva.co.il
E-mail:bioforum@bioforum.co.il Website: www.pba2019.org
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
